Assetmark Inc. Has $764,000 Stock Position in Envista Holdings Co. (NYSE:NVST)

Assetmark Inc. boosted its position in shares of Envista Holdings Co. (NYSE:NVSTFree Report) by 5.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,641 shares of the company’s stock after purchasing an additional 2,152 shares during the period. Assetmark Inc.’s holdings in Envista were worth $764,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the stock. Ariel Investments LLC increased its stake in Envista by 11.0% in the second quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock valued at $164,157,000 after acquiring an additional 978,952 shares during the last quarter. Nuance Investments LLC lifted its holdings in Envista by 47.2% in the second quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock valued at $117,048,000 after buying an additional 2,256,993 shares during the period. American Century Companies Inc. grew its stake in Envista by 15.4% in the second quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock valued at $111,864,000 after acquiring an additional 897,141 shares during the period. Jupiter Asset Management Ltd. bought a new stake in Envista during the 2nd quarter worth approximately $69,534,000. Finally, Van Lanschot Kempen Investment Management N.V. lifted its position in shares of Envista by 32.9% during the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 2,936,916 shares of the company’s stock worth $48,841,000 after buying an additional 727,406 shares in the last quarter.

Envista Stock Up 2.4 %

Envista stock opened at $20.57 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The stock has a market capitalization of $3.54 billion, a price-to-earnings ratio of -2.65, a PEG ratio of 2.83 and a beta of 1.30. Envista Holdings Co. has a 1-year low of $15.15 and a 1-year high of $25.64. The business has a fifty day moving average price of $19.20 and a 200-day moving average price of $18.13.

Envista (NYSE:NVSTGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business had revenue of $601.00 million during the quarter, compared to analysts’ expectations of $590.34 million. During the same quarter in the previous year, the firm posted $0.43 EPS. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. Equities research analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on NVST shares. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and lifted their price objective for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Bank of America reduced their target price on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. Needham & Company LLC reissued a “hold” rating on shares of Envista in a report on Thursday, October 31st. Piper Sandler upped their price target on Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Finally, Evercore ISI upped their price objective on Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $20.71.

Read Our Latest Stock Report on NVST

About Envista

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.